IPO registrations (S-1, F-1) · Registrants

Protara Therapeutics, Inc.

SEC CIK

1359931 · filings on EDGAR ↗

Name on the registration

PROTEON THERAPEUTICS INC

Former names

ArTara Therapeutics, Inc. (2019–2020); PROTEON THERAPEUTICS INC (2006–2019)

Registration

Form S-1, first filed 2014-09-16, last 2019-03-14; 2 initial registrations, 1 amendment

Outcome

Final prospectus filed 2014-10-22; declared effective 2014-10-21; withdrawal requested 2019-12-20

Industry (SIC)

Biological Products, (No Diagnostic Substances) 2836

Business address

345 PARK AVENUE SOUTH, 3RD FLOOR, New York, NY 10010

EIN

20-4580525

Ticker

TARA (Nasdaq)

EDGAR entity type

operating

Insiders and CEO pay

Protara Therapeutics, Inc. on the corporate pages

Offering terms

Proposed price range

$12.00–$14.00 per share (S-1/A filed 2014-10-07)

Final price

$10.00 per share, below the range (424B4 filed 2014-10-22, an initial public offering)

Shares sold

6,110,000

Gross proceeds

$61,100,000 before underwriting discounts and any over-allotment option

Listing

Nasdaq under the symbol PRTO

Lead underwriters

Stifel (2,444,000 shares); JMP Securities (1,833,000 shares)

Syndicate

Baird (916,500); Oppenheimer (916,500)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Business registration: PROTARA THERAPEUTICS, INC. Fuzzy (name and state)
• Form 5500 plan sponsor: PROTEON THERAPEUTICS, INC. EXACT (EIN (EXACT))
• Form D issuer: PROTEON THERAPEUTICS INC EXACT (CIK (EXACT))
• SEC filer: ArTara Therapeutics, Inc. EXACT (CIK (EXACT))
• Person page: James E Flynn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (DirectorOther))
• Person page: Luke M Beshar Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))

Filings 14

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), NY first:

• Acorda Therapeutics, Inc. NY
• BRAINSTORM CELL THERAPEUTICS INC. NY
• ANAVEX LIFE SCIENCES CORP. NY
• CytRx Oncology Corp NY
• Omrix Biopharmaceuticals, Inc. NY
• COGNITION THERAPEUTICS INC NY
• Bavarian Nordic A/S / ADR NY
• Qrons Inc. NY
• Prevail Therapeutics Inc. NY
• MeiraGTx Holdings plc NY

More with this interest.

In other datasets, the same topic (Health) in NY:

• Nonprofit: AABR FOUNDATION INC (Nonprofits (IRS Form 990))

Interests: Biological Products, (No Diagnostic Substances) · Health